Vera Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeVera Therapeutics
Vera Therapeutics logo

Vera Therapeutics

0 followers

VERA

Performance

About Vera Therapeutics

Vera Therapeutics is a clinical-stage biotechnology company focusing on developing treatments for immunological diseases that improve patients’ lives, with a particular emphasis on IgA nephropathy and related kidney immune disorders. The company conducts research and clinical development to advance therapies for immune-mediated nephropathies, aiming to set new standards in patient care. Its publicly highlighted programs include atacicept in IgAN and other immune-related conditions, with scientific publications and medical affairs supporting clinical insights. Vera Therapeutics operates internationally through a research-driven biopharma approach, communicating its advancements and patient impact through its website and affiliated channels.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Robert M. Brenner, MD

Chief Medical Officer

Jason Carter

Chief Legal Officer

Lauren Frenz, MBA

Chief Business Officer

Marshall Fordyce, MD

CEO and Founder

Key Facts

HQ Location

Brisbane, United States

Founded

2016

Employees

51 - 200

Status

Public

Website

https://veratx.com